SelectQuote (SLQT)
NYSE:SLQT
Want to see SLQT full AI Analyst Report?
Earnings Data
Report Date
Sep 16, 2026After Close (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
-0.17Last Year’s EPS
-0.02Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed solid operational and financial progress: revenue grew 6% to $431M, adjusted EBITDA rose 18% to $45M, Senior and Healthcare Services showed tangible improvements, SelectRx demonstrated membership and efficiency momentum, and management reiterated guidance and a path to stronger cash flow in fiscal 2027. Offsetting items include IRA-driven top-line effects, earlier PBM reimbursement headwinds (now reportedly stabilized), reliance on a $14M favorable change in estimate that aided results, and potential timing-related volatility in MA approval rates that could affect Q4. Management emphasized backbook visibility (nearly $1B commissions receivable) and multiple strategic options to close the valuation gap. On balance, operational strengths and clear pathways to improved cash flow outweigh the near-term headwinds and accounting nuances.Company Guidance
Consolidated Revenue Growth
SelectQuote reported consolidated revenue of $431 million, up 6% year-over-year.
Adjusted EBITDA Expansion
Adjusted EBITDA totaled $45 million, an 18% year-over-year increase; excluding a favorable $14 million change in estimate, consolidated EBITDA margin for the quarter would have been ~7%.
Senior Segment Strength
Senior revenue grew 8% year-over-year to $183 million on 4% growth in approved MA policies; Senior adjusted EBITDA was $59 million (includes $14M favorable change); excluding the adjustment, Senior delivered a 26% EBITDA margin and has maintained ≥25% profitability in AEP/OEP seasons for four consecutive years.
Commissions Receivable and Backbook Visibility
Medicare Advantage commissions receivable balance is nearly $1 billion; company recorded a $14 million favorable change in estimate based on increased expected renewals and cited a recapture/renewal experience above ~33% (firm references a 34% recapture rate), supporting backbook cash-flow visibility.
SelectRx Member and Operational Momentum
Healthcare Services (SelectRx) revenue was $199 million with membership of ~117,000 and membership growth of 11% year-over-year; prescriptions shipped rose 64% versus two years ago while SelectRx adjusted EBITDA improved sequentially to $5 million.
Path to Meaningful SelectRx Profitability
Management reiterated confidence that SelectRx can reach a $40 million to $50 million EBITDA run rate in the very near term, supported by operational efficiencies from the Olathe, KS facility.
Facility Efficiency and Scalability
Olathe, Kansas distribution facility (less than 20% of prescriptions today) is delivering 30%+ efficiency gains versus legacy locations and has substantial unused capacity to scale output and improve margins.
Marketing and Productivity Improvements
Agent productivity improved (policies per agent +1% versus two years ago) and marketing efficiency improved (14% less spent per approved policy versus two years ago); company reported a consolidated revenue-to-CAC multiple of 6.7x.
Life Insurance Steady Contribution
Life revenue grew 4% to $48 million and produced adjusted EBITDA of $6 million; Final Expense commissions were up more than 8% year-over-year and remain a consistent growth driver.
Reaffirmed Full-Year Guidance
Management reaffirmed fiscal 2026 guidance: revenue range $1.61B–$1.71B and adjusted EBITDA $90M–$100M, signaling confidence despite quarter-specific dynamics.
SLQT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SLQT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 05, 2026 | $0.81 | $1.24 | +52.52% |
Feb 05, 2026 | $1.45 | $1.03 | -28.97% |
Nov 06, 2025 | $2.13 | $1.68 | -21.13% |
Aug 21, 2025 | $1.83 | $2.59 | +41.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does SelectQuote (SLQT) report earnings?
SelectQuote (SLQT) is schdueled to report earning on Sep 16, 2026, After Close (Confirmed).
What is SelectQuote (SLQT) earnings time?
SelectQuote (SLQT) earnings time is at Sep 16, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SLQT EPS forecast?
SLQT EPS forecast for the fiscal quarter 2026 (Q4) is -0.17.